Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · IEX Real-Time Price · USD
0.627
+0.061 (10.76%)
At close: Jul 19, 2024, 4:00 PM
0.630
+0.003 (0.48%)
Pre-market: Jul 22, 2024, 7:26 AM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $353.49 thousand as of July 22, 2024. Its market cap has decreased by -91.97% in one year.
Market Cap
353.49K
Enterprise Value
-1.99M
1-Year Change
-91.97%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $126.38M to $353.49K, a decrease of -99.72%. That is a compound annual growth rate of -88.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 200.00K | -86.67% |
| Dec 29, 2023 | 1.50M | -80.52% |
| Dec 30, 2022 | 7.70M | -84.57% |
| Dec 31, 2021 | 49.90M | -60.52% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bone Biologics | 1.22M |
| Dermata Therapeutics | 1.20M |
| Salarius Pharmaceuticals | 1.09M |
| GRI Bio | 1.01M |
| China SXT Pharmaceuticals | 793.36K |
| Biodexa Pharmaceuticals | 189.21K |